The invention pertains to medical devices and, more particularly, to medical devices, such as guidewires, catheters, or the like, having improved flexibility characteristics.
A wide variety of medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires or catheters that have certain flexibility characteristics. Of the known medical devices that have defined flexibility characteristics, each has certain advantages and disadvantages. There is an ongoing need to provide alternative designs and methods of making and using medical devices with desirable flexibility characteristics.
The invention provides design, material, and manufacturing method alternatives for medical devices having certain flexibility characteristics. In at least some embodiments, the medical devices include an elongate shaft that has a proximal portion, a distal portion, and an intermediate portion disposed between the proximal and distal portions that includes a region having a flexibility that is greater than that of the distal portion or the proximal portion.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a” , “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings illustrate example embodiments of the claimed invention.
A number of different medical devices, for example guidewires, catheters, and the like, are used in certain medical procedures and for treating many types of disease. For example, an intravascular device can be inserted into the vascular system of the patient and navigated through the vasculature to a desired target site. Using this method, virtually any target site in the patient's vascular system may be accessed, including, for example, the coronary, cerebral, and peripheral vasculature.
When in use, such a medical device enters the patient's anatomy at a predetermined location and then is advanced toward a target region. While advancing the device a clinician may urge the distal tip forward by applying longitudinal forces to the proximal portion of the device. For the device to effectively communicate these longitudinal forces, it is desirable that the device have a high level of pushability or stiffness, particularly near the proximal end. Moreover, the path taken by a device within the anatomy may be tortuous, requiring the device to change direction frequently. In order for the device to navigate the tortuous anatomy, it is desirable for it to have certain flexibility characteristics, particularly near the distal end. The need for this combination of performance features is often addressed by manufacturing a medical device that has two or more discrete regions having different performance characteristics. For example, a relatively flexible distal section may be connected to a relatively rigid proximal section.
In some instances, the anatomy that the medical device is being advanced through may be partially or completely occluded. A number of complications could occur if the medical device encounters a partial or total occlusion. For example, the flexible distal tip could deflect and, possibly, damage or perforate a blood vessel or other anatomy through which it is navigating. In at least some embodiments, the invention includes a medical device with improved flexibility characteristics. For example, the device may include an increased flexibility portion located proximally of the distal tip that may act as a push force limiting structure, as described in more detail below.
Intermediate portion 20 generally provides device 10 with a region having a decreased column strength or increased flexibility than the column strength or flexibility at a distal end 21 of device 10. Although the individual portions of device 10 have been called out as the proximal 16, distal 18, and intermediate portions 20, it can be appreciated that these names are not intended to limit the precise position of intermediate portion 20. For example, in at least some embodiments device 10 may include a generally stiff proximal portion 16 and a generally flexible distal portion 18. Additionally, the stiffness of proximal and distal portion 16/18 may vary along the length. Intermediate portion 20 can then be placed at essentially any position along the length of shaft 14. For example, intermediate portion 20 may be disposed between proximal and distal portion 16/18, within a region of proximal portion 16, within a region of distal portion 18, or even distally of distal portion 18. Because intermediate portion 20 generally provides a point of increased flexibility relative to the distal end of shaft 14, the later embodiment of device 10 would include a tip portion extending distally of intermediate portion 20 and distal portion 18.
Buckling is generally understood to be a change in shape of device 10 that results in at least some lateral displacement of at least a portion of intermediate portion 20 that diverts force away from or prevents force from being transmitted to distal tip 18. Diverting or preventing the transmission of force to distal tip 18 can result in a reduced or nominal amount of displacement of distal tip 18. Thus, as force is applied to proximal portion of 16 in the distal direction, device 10 advances distally. When distal tip 18 encounters a barrier, additional distal force is diverted from distal tip 18 by the buckling of intermediate portion 20. As such, intermediate portion 20 acts as a push force limiter by limiting the amount of force that can be transmitted from proximal portion 16 to distal tip 18.
The buckling feature of device 10 can be achieved at or adjacent intermediate portion 20 by utilizing a number a different strategies. In some embodiments, the materials used to manufacture device 10 can be chosen so that intermediate portion 20 includes the desired buckling feature. For example, the different portions of shaft 14 can be made of any suitable materials including metals, metal alloys, polymers, or the like, or combinations or mixtures thereof. Some examples of suitable metals and metal alloys include stainless steel, such as 304v stainless steel; nickel-titanium alloy, such as nitinol, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, or the like; or other suitable material. The word nitinol was coined by a group of researchers at the United States Naval Ordinance Laboratory (NOL) who were the first to observe the shape memory behavior of this material. The word nitinol is an acronym including the chemical symbol for nickel (Ni), the chemical symbol for titanium (Ti), and an acronym identifying the Naval Ordinance Laboratory (NOL). Some examples of suitable polymers may include PTFE, fluorinated ethylene propylene (FEP), polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example a polyether-ester elastomer such as ARNITEL® available from DSM Engineering Plastics), polyester (for example a polyester elastomer such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID(® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), silicones, polyethylene, Marlex high-density polyethylene, linear low density polyethylene (for example REXELL®), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), other suitable materials, or mixtures, combinations, or copolymers thereof. In some embodiments intermediate portion 20 can include a liquid crystal polymer (LCP) blended with other polymers to enhance torqueability.
In general, the materials used to construct device 10 can be chosen so that proximal portion 16 can be relatively stiff for pushability and torqueability, and distal portion 18 can be relatively flexible by comparison for better lateral trackability and steerability. For example, proximal portion 16 can be formed of straightened 304v stainless steel wire or ribbon, and distal portion 18 can be formed of a straightened super elastic or linear elastic alloy, for example a nickel-titanium alloy wire or ribbon. The materials used to construct intermediate portion 20 can then be chosen relative to those chosen for portions 16/18 in order to impart the desired push force limiting effect. For example, intermediate portion 20 can be manufactured from a metal, metal alloy, or polymer that is more flexible than the material used to construct distal tip 18. For example, in some example embodiments, proximal portion 16 can be constructed of rigid stainless steel, distal portion 18 can be nickel-titanium alloy, and intermediate portion 20 can be nickel-titanium alloy having more flexibility and less column strength than distal portion 18. Alternatively, all of shaft 14, or the distal and intermediate portions 18, 20 may be constructed from a single material, and be configured so that intermediate portion 20 has more flexibility and less column strength than distal portion 18. For example, all of shaft 14, or the distal and intermediate portions 18, 20 may be constructed from a nickel-titanium alloy, and be configured so that intermediate portion 20 has more flexibility and less column strength than distal portion 18.
The desired results can be achieved by employing selection of materials, processing, and/or structural techniques. More particularly, the use of different materials different processing techniques, different structure, or a combination of all of these allows different embodiments of intermediate portion 20 to be more flexible than the distal portion 18.
In some embodiments, the intermediate portion 20 can be engineered to buckle at a predetermined force and/or be tuned to buckle at a specific force. Thus, in embodiments where device 10 is a guidewire being advanced toward a total occlusion, it may be desirable to manufacture or configure intermediate portion 20 so that it will buckle before the pushing forces become high enough that distal tip 18 could displace and perforate, for example, a blood vessel.
In some embodiments, the materials, geometry, mechanical workings, structure, etc. can be used to design the push force limiting intermediate portion 20 to buckle at a specific predetermined force, thereby preventing additional force from being transmitted to the tip. In some embodiments, the amount of force at which point intermediate portion 20 will buckle can be in the range of about 0.01 Newtons to about 2.2 Newtons, or in the range of about 0.02 pound to about 0.5 pound.
Variations in materials, geometries, mechanical workings, etc. can also result in the shape or direction of the “buckle” to vary. For example, some configurations of intermediate portion 20 result in a generally lateral deflection when buckling. Alternatively, other embodiments include intermediate portion 20 being configured to buckle in a generally spiraling, looping, or helical manner. This configuration may allow intermediate portion 20 (and/or the buckled portion thereof) to buckle over a larger longitudinal distance and a smaller lateral distance. This feature may be desirable, for example, when device 10 is being used in relatively small or stenotic vessels.
In some embodiments, a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all or portions of device 10. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which can improve guidewire handling and device exchanges. Lubricious coatings can also improve steerability and lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.
In at least some embodiments, portions or all of device 10 may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of device 10 in determining its location. For example, intermediate portion 20 may include radiopaque materials so that the clinician can monitor for the presence of any buckling. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like.
The different portions of device 10 can be connected using any suitable connecting technique such as welding, soldering, brazing, adhesive, mechanical interlocking, or the like, or combinations thereof. In some embodiments, the different portions of device 10 may be integral with one another or generally made of the same material but structurally different from one another. Alternatively, some embodiments can include one or more mechanical connectors or connector assemblies to connect the different portions of the core wire that are made of different materials. The connector may include any structure generally suitable for connecting portions of a guidewire. One example of a suitable structure includes a structure such as a hypotube or a coiled wire which has an inside diameter sized appropriately to receive and connect to the ends of proximal portion 16 and distal portion 18. Some other examples of suitable techniques and structures that can be used to interconnect different shaft sections are disclosed in U.S. Pat. No. 6,918,882, which is incorporated herein by reference.
The length of device 10, or the length of individual portions thereof, are typically dictated by the length and flexibility characteristics desired in the final medical device. In some example embodiments, proximal portion 16 may have a length in the range of about 20 to about 300 centimeters or more and distal portion 18 may have a length in the range of about 3 to about 50 centimeters or more. In some embodiments, the length of intermediate portion 20 may be in the range of about 5 centimeter or less, for example about 1 centimeter or less. It can be appreciated that alterations in the length of portions 16/18/20 can be made without departing from the spirit of the invention.
In addition, shaft 14 can have a solid cross-section, but in some embodiments, can have a hollow cross-section. In yet other embodiments, shaft 14 can include a combination of areas having solid cross-sections and hollow cross sections. Moreover, shaft 14, or portions thereof, can be made of rounded wire, flattened ribbon, or other such structures having various cross-sectional geometries. The cross sectional geometries along the length of shaft 14 can also be constant or can vary.
In some other embodiments, for example, with reference to
Notches 122 may also allow intermediate potion 120 to be manufactured from the same material or from materials having a similar flexibility as proximal portion 16 and/or distal tip 20. For example, distal tip 21 may include linear-elastic or super-elastic nickel-titanium alloy and intermediate portion 120 may be defined by a region of the nickel-titanium alloy that includes notches 122. Similarly, proximal portion 16 may be comprised of a metal (e.g., stainless steel, nickel-titanium alloy, and the like including those described herein) and intermediate portion 120 may be defined by a region that includes notches 122. Although notches 122 are depicted as being squared in shape in
The number of notches 122 may also vary and include numbers between one and any other appropriate number. For example,
Another example medical device 210 is shown in
Coil 224 can be manufactured from a number of suitable materials, including, for example, metals, metal alloys, polymers, metal-polymer composites, and the like. Some examples of materials include stainless steel, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, platinum, or other suitable materials, and the like. Some additional examples of suitable material include straightened super elastic or linear elastic alloy (e.g., nickel-titanium) wire, or alternatively, a polymer material, such as a high performance polymer. In some embodiments, coil 224 can be made of ,in full or in part, coated with, or doped with a radiopaque material.
Coil 224 may be formed of round wire or flat ribbon ranging in dimensions to achieve the desired characteristics, such as flexibility, and be wrapped in a generally helical fashion by conventional winding techniques. The pitch of adjacent turns of coil 224 may be tightly wrapped so that each turn touches the succeeding turn or the pitch may be set such that coil 224 is wrapped in an open fashion. Moreover, the pitch of the coil can be varied along the length device 210. In some embodiments, a coating, for example a lubricious (e.g., hydrophylic) or other type of coating may be applied over portions or all of coil 224. Some examples of such coatings include those discussed above. Additionally, the thickness of coil 224 may be varied along the longitudinal axis of the device 210.
Coil 224 may include a proximal end 226 that is coupled to or otherwise attached to proximal portion 16. Coil 224 can be attached using suitable attachment mechanism, for example a solder joint or other suitable attachment means such as adhesive, thermal bonding, mechanical bonding, and the like. A distal end 228 of coil 224 may be coupled to distal tip portion 18, for example, analogously to how proximal end 226 is coupled to proximal portion 16 or by any other suitable connection.
Another example medical device 610 is shown in
Medical devices including such push force limiting structure can also include additional structure. For example, such structures as a coil, a sheath, a shaping ribbon, a marker member, a solder tip, or the like can be present on the device, for example, near the distal end, or on other portions of the device. For example,
In at least some embodiments, intermediate portion 320 is located a distance away from a distal end 330 of distal portion 318. For example, distal portion may have a length of about 1-300 centimeters or longer and intermediate portion 320 may be located about 1-50 centimeters from distal end 330. Moreover, the length, shape, materials, configuration, etc. of intermediate portion may be substantially similar to the example embodiments of intermediate portions 20/120/220 described above. For example, the materials used to manufacture intermediate portion 320 may include a polymer, metal, or any other material including those described herein that has a flexibility that is greater than the material found at regions of distal portion 318 that are located distally of intermediate portion 320.
As shown in
The tapered and constant diameter portions of tapered region may be formed by any one of a number of different techniques, for example, by centerless grinding methods, stamping methods, and the like. The centerless grinding technique may utilize an indexing system employing sensors (e.g., optical/reflective, magnetic) to avoid excessive grinding of the connection. In addition, the centerless grinding technique may utilize a CBN or diamond abrasive grinding wheel that is well shaped and dressed to avoid grabbing shaft 314 during the grinding process. In some embodiments, shaft 314 is centerless ground using a Royal Master HI-AC centerless grinder.
The cross-sectional shape of shaft 314 may also vary. For example,
Sheath 334 may be manufactured from a suitable material such as a metal or metal alloy, a polymer, a metal-polymer composite, and the like including any of those listed above. In some embodiments, sheath 334 may be multi-layer (indicated in
Another example medical device 410 is illustrated in
Another example medical device 710 is illustrated in
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1553227 | Feyk et al. | Sep 1925 | A |
| 1866888 | Hawley | Jul 1932 | A |
| 2275827 | Plensler | Mar 1942 | A |
| 2413805 | Vickers | Jan 1947 | A |
| 2441166 | Raspert | May 1948 | A |
| 2561890 | Stoddard | Jul 1951 | A |
| 2722614 | Fryklund | Nov 1955 | A |
| 2857536 | Light | Oct 1958 | A |
| 2864017 | Waltscheff | Dec 1958 | A |
| 2871793 | Michie et al. | Feb 1959 | A |
| 3249776 | Anderson et al. | May 1966 | A |
| 3322984 | Anderson | May 1967 | A |
| 3334253 | Hill | Aug 1967 | A |
| 3363470 | Yavne | Jan 1968 | A |
| 3452227 | Welch | Jun 1969 | A |
| 3452742 | Muller | Jul 1969 | A |
| 3463953 | Maxwell | Aug 1969 | A |
| 3512019 | Durand | May 1970 | A |
| 3544868 | Bates | Dec 1970 | A |
| 3625200 | Muller | Dec 1971 | A |
| 3686990 | Margolien | Aug 1972 | A |
| 3841308 | Tate | Oct 1974 | A |
| 3890977 | Wilson | Jun 1975 | A |
| 3906938 | Fleischhacker | Sep 1975 | A |
| 4000672 | Sitterer et al. | Jan 1977 | A |
| 4003369 | Heilman et al. | Jan 1977 | A |
| 4020829 | Willson et al. | May 1977 | A |
| 4050466 | Koerbacher | Sep 1977 | A |
| 4142119 | Madey | Feb 1979 | A |
| 4215703 | Willson | Aug 1980 | A |
| 4280500 | Ono | Jul 1981 | A |
| 4330725 | Hintz | May 1982 | A |
| 4425919 | Alston, Jr. et al. | Jan 1984 | A |
| 4476754 | Ducret | Oct 1984 | A |
| 4482828 | Vergues et al. | Nov 1984 | A |
| 4545390 | Leary | Oct 1985 | A |
| 4563181 | Wijayarathna et al. | Jan 1986 | A |
| 4574670 | Johnson | Mar 1986 | A |
| 4580551 | Siegmund et al. | Apr 1986 | A |
| 4583404 | Bernard et al. | Apr 1986 | A |
| 4635270 | Gürs | Jan 1987 | A |
| 4665906 | Jervis | May 1987 | A |
| 4676249 | Arenas et al. | Jun 1987 | A |
| 4721117 | Mar et al. | Jan 1988 | A |
| 4737153 | Shimamura et al. | Apr 1988 | A |
| 4763647 | Gambale | Aug 1988 | A |
| 4774949 | Fogarty | Oct 1988 | A |
| 4781092 | Gaiser | Nov 1988 | A |
| 4781186 | Simpson et al. | Nov 1988 | A |
| 4786220 | Fildes et al. | Nov 1988 | A |
| 4790331 | Okada et al. | Dec 1988 | A |
| 4800890 | Cramer | Jan 1989 | A |
| 4811743 | Stevens | Mar 1989 | A |
| 4827941 | Taylor et al. | May 1989 | A |
| 4831858 | Yoshizawa | May 1989 | A |
| 4832047 | Sepetka et al. | May 1989 | A |
| 4846186 | Box et al. | Jul 1989 | A |
| 4867173 | Leoni | Sep 1989 | A |
| 4875489 | Messner et al. | Oct 1989 | A |
| 4884579 | Engelson | Dec 1989 | A |
| 4911148 | Sosnowski et al. | Mar 1990 | A |
| 4917102 | Miller et al. | Apr 1990 | A |
| 4922164 | Jacobsen et al. | May 1990 | A |
| 4922777 | Kawabata | May 1990 | A |
| 4932959 | Horzewski et al. | Jun 1990 | A |
| 4934380 | Toledo | Jun 1990 | A |
| 4953553 | Tremulis | Sep 1990 | A |
| 4954022 | Underwood et al. | Sep 1990 | A |
| 4955384 | Taylor et al. | Sep 1990 | A |
| 4955862 | Sepetka | Sep 1990 | A |
| 4960410 | Pinchuk | Oct 1990 | A |
| 4964409 | Tremulis | Oct 1990 | A |
| 4966163 | Kraus et al. | Oct 1990 | A |
| 4968306 | Huss et al. | Nov 1990 | A |
| 4985022 | Fearnot et al. | Jan 1991 | A |
| 4989608 | Ratner | Feb 1991 | A |
| 4990143 | Sheridan | Feb 1991 | A |
| 4994069 | Ritchart et al. | Feb 1991 | A |
| 4998923 | Samson et al. | Mar 1991 | A |
| 5007434 | Doyle et al. | Apr 1991 | A |
| 5009137 | Dannatt | Apr 1991 | A |
| 5040543 | Badera et al. | Aug 1991 | A |
| 5050606 | Tremulis | Sep 1991 | A |
| 5052404 | Hodgson | Oct 1991 | A |
| 5059177 | Towne et al. | Oct 1991 | A |
| 5063935 | Gamble | Nov 1991 | A |
| 5065769 | De Toledo | Nov 1991 | A |
| 5095915 | Engelson | Mar 1992 | A |
| 5106455 | Jacobsen et al. | Apr 1992 | A |
| 5109830 | Cho | May 1992 | A |
| 5125395 | Adair | Jun 1992 | A |
| 5135531 | Shiber | Aug 1992 | A |
| 5144959 | Gambale et al. | Sep 1992 | A |
| 5147317 | Shank et al. | Sep 1992 | A |
| 5181668 | Tsuji et al. | Jan 1993 | A |
| 5205830 | Dassa et al. | Apr 1993 | A |
| 5211183 | Wilson | May 1993 | A |
| 5213111 | Cook et al. | May 1993 | A |
| 5228441 | Lundquist | Jul 1993 | A |
| 5228453 | Sepetka | Jul 1993 | A |
| 5238004 | Sahatjian et al. | Aug 1993 | A |
| 5242759 | Hall | Sep 1993 | A |
| 5243996 | Hall | Sep 1993 | A |
| 5250069 | Nobuyoshi et al. | Oct 1993 | A |
| 5254106 | Feaster | Oct 1993 | A |
| 5254107 | Soltesz | Oct 1993 | A |
| 5256144 | Kraus et al. | Oct 1993 | A |
| 5257974 | Cox | Nov 1993 | A |
| 5259393 | Corso, Jr. et al. | Nov 1993 | A |
| 5267979 | Appling et al. | Dec 1993 | A |
| 5267982 | Sylvanowicz | Dec 1993 | A |
| 5279562 | Sirhan et al. | Jan 1994 | A |
| 5284128 | Hart | Feb 1994 | A |
| 5300032 | Hibbs et al. | Apr 1994 | A |
| 5304131 | Paskar | Apr 1994 | A |
| 5306252 | Yutori et al. | Apr 1994 | A |
| 5308435 | Ruggles et al. | May 1994 | A |
| 5314418 | Takano et al. | May 1994 | A |
| 5315906 | Ferenczi et al. | May 1994 | A |
| 5315996 | Lundquist | May 1994 | A |
| 5318529 | Kontos | Jun 1994 | A |
| 5322064 | Lundquist | Jun 1994 | A |
| 5329923 | Lundquist | Jul 1994 | A |
| 5333620 | Moutafis et al. | Aug 1994 | A |
| 5334145 | Lundquist et al. | Aug 1994 | A |
| 5336205 | Zenzen et al. | Aug 1994 | A |
| 5341818 | Abrams et al. | Aug 1994 | A |
| 5345937 | Middleman et al. | Sep 1994 | A |
| 5345945 | Hodgson et al. | Sep 1994 | A |
| 5354623 | Hall | Oct 1994 | A |
| 5358493 | Schweich et al. | Oct 1994 | A |
| 5358796 | Nakamura et al. | Oct 1994 | A |
| 5365942 | Shank | Nov 1994 | A |
| 5365943 | Jansen | Nov 1994 | A |
| 5368564 | Savage | Nov 1994 | A |
| 5368661 | Nakamura et al. | Nov 1994 | A |
| 5376084 | Bacich et al. | Dec 1994 | A |
| 5381782 | DeLaRama et al. | Jan 1995 | A |
| 5406960 | Corso, Jr. | Apr 1995 | A |
| 5411476 | Abrams | May 1995 | A |
| 5433200 | Fleischhacker, Jr. | Jul 1995 | A |
| 5437288 | Schwartz et al. | Aug 1995 | A |
| 5438993 | Lynch et al. | Aug 1995 | A |
| 5439000 | Gunderson et al. | Aug 1995 | A |
| 5441483 | Avitall | Aug 1995 | A |
| 5441489 | Utsumi et al. | Aug 1995 | A |
| 5447812 | Fukuda et al. | Sep 1995 | A |
| 5454787 | Lundquist | Oct 1995 | A |
| 5460187 | Daigle et al. | Oct 1995 | A |
| 5470330 | Goldenberg et al. | Nov 1995 | A |
| 5476701 | Berger | Dec 1995 | A |
| 5477856 | Lundquist | Dec 1995 | A |
| 5496294 | Hergenrother et al. | Mar 1996 | A |
| 5497785 | Viera | Mar 1996 | A |
| 5507301 | Wasicek et al. | Apr 1996 | A |
| 5507729 | Lindenberg et al. | Apr 1996 | A |
| 5507751 | Goode et al. | Apr 1996 | A |
| 5507766 | Kugo et al. | Apr 1996 | A |
| 5514128 | Hillsman et al. | May 1996 | A |
| 5520194 | Miyata et al. | May 1996 | A |
| 5520645 | Imran et al. | May 1996 | A |
| 5531719 | Takahashi | Jul 1996 | A |
| 5533985 | Wang | Jul 1996 | A |
| 5546958 | Thorud et al. | Aug 1996 | A |
| 5551444 | Finlayson | Sep 1996 | A |
| 5554139 | Okajima | Sep 1996 | A |
| 5562619 | Mirarchi et al. | Oct 1996 | A |
| 5569197 | Helmus et al. | Oct 1996 | A |
| 5569200 | Umeno et al. | Oct 1996 | A |
| 5569218 | Berg | Oct 1996 | A |
| 5571073 | Castillo | Nov 1996 | A |
| 5573520 | Schwartz et al. | Nov 1996 | A |
| 5584821 | Hobbs et al. | Dec 1996 | A |
| 5599326 | Carter | Feb 1997 | A |
| 5599492 | Engelson | Feb 1997 | A |
| 5601539 | Corso, Jr. | Feb 1997 | A |
| 5605162 | Mirazee et al. | Feb 1997 | A |
| 5622184 | Ashby et al. | Apr 1997 | A |
| 5630806 | Inagaki et al. | May 1997 | A |
| 5637089 | Abrams et al. | Jun 1997 | A |
| 5656011 | Uihlein et al. | Aug 1997 | A |
| 5658264 | Samson et al. | Aug 1997 | A |
| 5666968 | Imran et al. | Sep 1997 | A |
| 5666969 | Urick et al. | Sep 1997 | A |
| 5669926 | Aust et al. | Sep 1997 | A |
| 5676659 | McGurk | Oct 1997 | A |
| 5676697 | McDonald | Oct 1997 | A |
| 5682894 | Orr et al. | Nov 1997 | A |
| 5690120 | Jacobsen et al. | Nov 1997 | A |
| 5720300 | Fagan et al. | Feb 1998 | A |
| 5728063 | Preissman et al. | Mar 1998 | A |
| 5741429 | Donadio, III et al. | Apr 1998 | A |
| 5746701 | Noone | May 1998 | A |
| 5769830 | Parker | Jun 1998 | A |
| 5772609 | Nguyen et al. | Jun 1998 | A |
| 5782809 | Umeno et al. | Jul 1998 | A |
| 5788653 | Lorenzo | Aug 1998 | A |
| 5788654 | Schwager | Aug 1998 | A |
| 5788707 | Del Toro et al. | Aug 1998 | A |
| 5792124 | Horrigan et al. | Aug 1998 | A |
| 5797856 | Frisbie et al. | Aug 1998 | A |
| 5800454 | Jacobsen et al. | Sep 1998 | A |
| 5807075 | Jacobsen et al. | Sep 1998 | A |
| 5807249 | Qin et al. | Sep 1998 | A |
| 5810885 | Zinger | Sep 1998 | A |
| 5813996 | St. Germain et al. | Sep 1998 | A |
| 5827225 | Ma Schwab | Oct 1998 | A |
| 5827242 | Follmer et al. | Oct 1998 | A |
| 5833632 | Jacobsen et al. | Nov 1998 | A |
| 5836926 | Peterson et al. | Nov 1998 | A |
| 5843050 | Jones et al. | Dec 1998 | A |
| 5843244 | Pelton et al. | Dec 1998 | A |
| 5851203 | van Muiden | Dec 1998 | A |
| 5891056 | Ramzipoor | Apr 1999 | A |
| 5895378 | Nita | Apr 1999 | A |
| 5897537 | Berg et al. | Apr 1999 | A |
| 5902254 | Magram | May 1999 | A |
| 5902290 | Peacock, III et al. | May 1999 | A |
| 5904657 | Unsworth et al. | May 1999 | A |
| 5906618 | Larson, III | May 1999 | A |
| 5911715 | Berg et al. | Jun 1999 | A |
| 5911717 | Jacobsen et al. | Jun 1999 | A |
| 5916177 | Schwager | Jun 1999 | A |
| 5916178 | Noone | Jun 1999 | A |
| 5916194 | Jacobsen et al. | Jun 1999 | A |
| 5931819 | Fariabi | Aug 1999 | A |
| 5931830 | Jacobsen et al. | Aug 1999 | A |
| 5935108 | Katoh et al. | Aug 1999 | A |
| 5947940 | Beisel | Sep 1999 | A |
| 5951539 | Nita et al. | Sep 1999 | A |
| 5971975 | Mills et al. | Oct 1999 | A |
| 5980471 | Jafari | Nov 1999 | A |
| 6001068 | Uchino et al. | Dec 1999 | A |
| 6004279 | Crowley et al. | Dec 1999 | A |
| 6014919 | Jacobsen et al. | Jan 2000 | A |
| 6017319 | Jacobsen et al. | Jan 2000 | A |
| 6022343 | Johnson et al. | Feb 2000 | A |
| 6022369 | Jacobsen et al. | Feb 2000 | A |
| 6024730 | Pagan | Feb 2000 | A |
| 6027461 | Walker et al. | Feb 2000 | A |
| 6042553 | Solar et al. | Mar 2000 | A |
| 6045547 | Ren et al. | Apr 2000 | A |
| 6048339 | Zirps et al. | Apr 2000 | A |
| 6056702 | Lorenzo | May 2000 | A |
| 6063101 | Jacobsen et al. | May 2000 | A |
| 6063200 | Jacobsen et al. | May 2000 | A |
| 6066361 | Jacobsen et al. | May 2000 | A |
| 6106485 | McMahon | Aug 2000 | A |
| 6106488 | Fleming et al. | Aug 2000 | A |
| 6113557 | Fagan et al. | Sep 2000 | A |
| 6120516 | Selmon et al. | Sep 2000 | A |
| 6139510 | Palermo | Oct 2000 | A |
| 6139543 | Esch et al. | Oct 2000 | A |
| 6165292 | Abrams et al. | Dec 2000 | A |
| 6171296 | Chow | Jan 2001 | B1 |
| 6183410 | Jacobsen et al. | Feb 2001 | B1 |
| 6183420 | Duek et al. | Feb 2001 | B1 |
| 6193686 | Estrada et al. | Feb 2001 | B1 |
| 6197014 | Samson et al. | Mar 2001 | B1 |
| 6203485 | Urick et al. | Mar 2001 | B1 |
| RE37148 | Shank | Apr 2001 | E |
| 6210400 | Hebert et al. | Apr 2001 | B1 |
| 6214042 | Jacobsen et al. | Apr 2001 | B1 |
| 6217527 | Selmon et al. | Apr 2001 | B1 |
| 6221049 | Selmon et al. | Apr 2001 | B1 |
| 6228073 | Noone et al. | May 2001 | B1 |
| 6231546 | Milo et al. | May 2001 | B1 |
| 6235000 | Milo et al. | May 2001 | B1 |
| 6241744 | Imran et al. | Jun 2001 | B1 |
| 6248082 | Jafari | Jun 2001 | B1 |
| 6251092 | Qin et al. | Jun 2001 | B1 |
| 6254469 | Angell et al. | Jul 2001 | B1 |
| 6254549 | Ramzipoor | Jul 2001 | B1 |
| 6260458 | Jacobsen et al. | Jul 2001 | B1 |
| 6273404 | Holman et al. | Aug 2001 | B1 |
| 6273876 | Klima et al. | Aug 2001 | B1 |
| 6273879 | Keith et al. | Aug 2001 | B1 |
| 6290656 | Boyle et al. | Sep 2001 | B1 |
| 6296616 | McMahon | Oct 2001 | B1 |
| 6296631 | Chow | Oct 2001 | B2 |
| 6302870 | Jacobsen et al. | Oct 2001 | B1 |
| 6306105 | Rooney et al. | Oct 2001 | B1 |
| 6325790 | Trotta | Dec 2001 | B1 |
| 6338725 | Hermann et al. | Jan 2002 | B1 |
| 6346091 | Jacobsen et al. | Feb 2002 | B1 |
| 6352515 | Anderson et al. | Mar 2002 | B1 |
| 6355005 | Powell et al. | Mar 2002 | B1 |
| 6355027 | Le et al. | Mar 2002 | B1 |
| 6368316 | Jansen et al. | Apr 2002 | B1 |
| 6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
| 6375774 | Lunn et al. | Apr 2002 | B1 |
| 6379369 | Abrams et al. | Apr 2002 | B1 |
| 6390993 | Cornish et al. | May 2002 | B1 |
| 6398758 | Jacobsen et al. | Jun 2002 | B1 |
| 6402706 | Richardson et al. | Jun 2002 | B2 |
| 6428489 | Jacobsen et al. | Aug 2002 | B1 |
| 6428512 | Anderson et al. | Aug 2002 | B1 |
| 6431039 | Jacobsen et al. | Aug 2002 | B1 |
| 6440088 | Jacobsen et al. | Aug 2002 | B1 |
| 6478778 | Jacobsen et al. | Nov 2002 | B1 |
| 6488637 | Eder et al. | Dec 2002 | B1 |
| 6491648 | Cornish et al. | Dec 2002 | B1 |
| 6491671 | Larson, III et al. | Dec 2002 | B1 |
| 6503244 | Hayman | Jan 2003 | B2 |
| 6506178 | Schubart et al. | Jan 2003 | B1 |
| 6508803 | Horikawa et al. | Jan 2003 | B1 |
| 6511458 | Milo et al. | Jan 2003 | B2 |
| 6524301 | Wilson et al. | Feb 2003 | B1 |
| 6527732 | Strauss et al. | Mar 2003 | B1 |
| 6530934 | Jacobsen et al. | Mar 2003 | B1 |
| 6547779 | Levine et al. | Apr 2003 | B2 |
| 6553880 | Jacobsen et al. | Apr 2003 | B2 |
| 6556873 | Smits | Apr 2003 | B1 |
| 6579246 | Jacobsen et al. | Jun 2003 | B2 |
| 6579302 | Duerig et al. | Jun 2003 | B2 |
| 6602207 | Mann et al. | Aug 2003 | B1 |
| 6602280 | Chobotov | Aug 2003 | B2 |
| 6610046 | Usami et al. | Aug 2003 | B1 |
| 6623448 | Slater | Sep 2003 | B2 |
| 6636758 | Sanchez et al. | Oct 2003 | B2 |
| 6638266 | Wilson et al. | Oct 2003 | B2 |
| 6652508 | Griffin et al. | Nov 2003 | B2 |
| 6682493 | Mirigian | Jan 2004 | B2 |
| 6689120 | Gerdts | Feb 2004 | B1 |
| 6702762 | Jafari et al. | Mar 2004 | B2 |
| 6712826 | Lui | Mar 2004 | B2 |
| 6730095 | Olson, Jr. et al. | May 2004 | B2 |
| 6749560 | Konstorum et al. | Jun 2004 | B1 |
| 6766720 | Jacobsen et al. | Jul 2004 | B1 |
| 6777644 | Peacock, III et al. | Aug 2004 | B2 |
| 6811544 | Schaer | Nov 2004 | B2 |
| 6837898 | Boyle et al. | Jan 2005 | B2 |
| 6866642 | Kellerman et al. | Mar 2005 | B2 |
| 6887235 | O'Connor et al. | May 2005 | B2 |
| 6918882 | Skujins et al. | Jul 2005 | B2 |
| 6997937 | Jacobsen et al. | Feb 2006 | B2 |
| 7001369 | Griffin et al. | Feb 2006 | B2 |
| 7074197 | Reynolds et al. | Jul 2006 | B2 |
| 7153277 | Skujins et al. | Dec 2006 | B2 |
| 7169118 | Reynolds et al. | Jan 2007 | B2 |
| 7182735 | Shireman et al. | Feb 2007 | B2 |
| 20010009980 | Richardson et al. | Jul 2001 | A1 |
| 20010012924 | Milo et al. | Aug 2001 | A1 |
| 20020013540 | Jacobsen et al. | Jan 2002 | A1 |
| 20020019599 | Rooney et al. | Feb 2002 | A1 |
| 20020082524 | Anderson et al. | Jun 2002 | A1 |
| 20020128677 | Duerig et al. | Sep 2002 | A1 |
| 20030009208 | Snyder et al. | Jan 2003 | A1 |
| 20030023261 | Tomaschko et al. | Jan 2003 | A1 |
| 20030060732 | Jacobsen et al. | Mar 2003 | A1 |
| 20030065316 | Levine et al. | Apr 2003 | A1 |
| 20030069520 | Skujins et al. | Apr 2003 | A1 |
| 20030069521 | Reynolds et al. | Apr 2003 | A1 |
| 20030069522 | Jacobsen et al. | Apr 2003 | A1 |
| 20030083643 | Wilson et al. | May 2003 | A1 |
| 20030139763 | Duerig et al. | Jul 2003 | A1 |
| 20030216668 | Howland et al. | Nov 2003 | A1 |
| 20040116831 | Vrba | Jun 2004 | A1 |
| 20040142643 | Miller et al. | Jul 2004 | A1 |
| 20040167437 | Sharrow et al. | Aug 2004 | A1 |
| 20040167441 | Reynolds et al. | Aug 2004 | A1 |
| 20040181174 | Davis et al. | Sep 2004 | A2 |
| 20040181176 | Jafari et al. | Sep 2004 | A1 |
| 20040243102 | Berg et al. | Dec 2004 | A1 |
| 20060121218 | Obara et al. | Jun 2006 | A1 |
| 20060122537 | Reynolds et al. | Jun 2006 | A1 |
| 20060189896 | Davis et al. | Aug 2006 | A1 |
| 20060264904 | Kerby et al. | Nov 2006 | A1 |
| 20080021347 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021348 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021400 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021401 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021402 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021403 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021404 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021405 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021406 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021407 | Jacobsen et al. | Jan 2008 | A1 |
| 20080021408 | Jacobsen et al. | Jan 2008 | A1 |
| 20080077119 | Snyder et al. | Mar 2008 | A1 |
| Number | Date | Country |
|---|---|---|
| 723040 | Dec 1997 | AU |
| 733966 | Apr 1998 | AU |
| PI 9712829 | Jan 2000 | BR |
| 2266685 | May 2006 | CA |
| 2255781 | Mar 2007 | CA |
| 1230914 | Oct 1999 | CN |
| 2539191 | Mar 1976 | DE |
| 285514 | Dec 1990 | DE |
| 0 045 931 | Feb 1982 | EP |
| 0 069 522 | Jan 1983 | EP |
| 0 087 933 | Sep 1983 | EP |
| 0 111 044 | Jun 1984 | EP |
| 0 181 174 | May 1986 | EP |
| 0377453 | Jul 1990 | EP |
| 0 565 065 | Jun 1996 | EP |
| 0 778 038 | Jun 1997 | EP |
| 0 778 039 | Jun 1997 | EP |
| 0 778 040 | Jun 1997 | EP |
| 0 812 599 | Dec 1997 | EP |
| 0 865 772 | Sep 1998 | EP |
| 0 865 773 | Sep 1998 | EP |
| 0 917 885 | May 1999 | EP |
| 0521595 | May 1999 | EP |
| 0 937 481 | Aug 1999 | EP |
| 0 790 066 | Apr 2000 | EP |
| 0608853 | Apr 2003 | EP |
| 0 935 947 | Dec 2004 | EP |
| 0 934 141 | Nov 2005 | EP |
| 03531 | Jul 1913 | GB |
| 2214354 | Aug 1989 | GB |
| 2257269 | Jan 1993 | GB |
| 58-8522 | Jan 1983 | JP |
| 60091858 | May 1985 | JP |
| 61022752 | Jan 1986 | JP |
| 62023361 | Jan 1987 | JP |
| 62089470 | Apr 1987 | JP |
| 62299277 | Dec 1987 | JP |
| 6393516 | Apr 1988 | JP |
| 63-181774 | Jul 1988 | JP |
| 63217966 | Sep 1988 | JP |
| 1089956 | Apr 1989 | JP |
| 1135363 | May 1989 | JP |
| 1158936 | Jun 1989 | JP |
| 2107268 | Apr 1990 | JP |
| 3081831 | Apr 1991 | JP |
| 03-122850 | Dec 1991 | JP |
| 4061840 | Feb 1992 | JP |
| 4099963 | Mar 1992 | JP |
| 4213069 | Aug 1992 | JP |
| 4213070 | Aug 1992 | JP |
| 4236965 | Aug 1992 | JP |
| 5149969 | Jun 1993 | JP |
| 5-506806 | Oct 1993 | JP |
| 5-309159 | Nov 1993 | JP |
| 5-507857 | Nov 1993 | JP |
| 6-501179 | Feb 1994 | JP |
| 631749 | Apr 1994 | JP |
| 6169996 | Jun 1994 | JP |
| 6-63224 | Sep 1994 | JP |
| 6312313 | Nov 1994 | JP |
| 728562 | May 1995 | JP |
| 7124164 | May 1995 | JP |
| 7124263 | May 1995 | JP |
| 7136280 | May 1995 | JP |
| 7148264 | Jun 1995 | JP |
| 7505561 | Jun 1995 | JP |
| 7037199 | Jul 1995 | JP |
| 7185009 | Jul 1995 | JP |
| 7255855 | Oct 1995 | JP |
| 7275366 | Oct 1995 | JP |
| 751067 | Nov 1995 | JP |
| 8-229888 | Sep 1996 | JP |
| 8509141 | Oct 1996 | JP |
| 8-317988 | Dec 1996 | JP |
| 9000164 | Apr 1997 | JP |
| 9-276413 | Oct 1997 | JP |
| 9-294813 | Nov 1997 | JP |
| 10-118193 | May 1998 | JP |
| 10328191 | Dec 1998 | JP |
| 11-267224 | Oct 1999 | JP |
| 2000-197704 | Jul 2000 | JP |
| 2000-510722 | Aug 2000 | JP |
| 2000-511083 | Aug 2000 | JP |
| 2001-500808 | Jan 2001 | JP |
| 3325828 | Jul 2002 | JP |
| 2002-529137 | Sep 2002 | JP |
| 2002-542901 | Dec 2002 | JP |
| 2002-543896 | Dec 2002 | JP |
| 2003-517893 | Jun 2003 | JP |
| 3649604 | Feb 2005 | JP |
| 2005-534407 | Nov 2005 | JP |
| 712908 | Jan 1980 | SU |
| 758421 | Aug 1980 | SU |
| 1529365 | Dec 1989 | SU |
| 9002520 | Mar 1990 | WO |
| WO 9113364 | Sep 1991 | WO |
| WO 9204072 | Mar 1992 | WO |
| 9207619 | May 1992 | WO |
| 9304722 | Mar 1993 | WO |
| WO 9311313 | Jun 1993 | WO |
| WO 9524236 | Sep 1995 | WO |
| WO 9619255 | Jun 1996 | WO |
| WO 9710022 | Mar 1997 | WO |
| WO 9725914 | Jul 1997 | WO |
| WO 9743949 | Nov 1997 | WO |
| WO 9744083 | Nov 1997 | WO |
| WO 9744086 | Nov 1997 | WO |
| WO 9810694 | Mar 1998 | WO |
| WO 9904847 | Feb 1999 | WO |
| WO 9911313 | Mar 1999 | WO |
| WO 0027303 | May 2000 | WO |
| WO 0030710 | Jun 2000 | WO |
| WO 0048645 | Aug 2000 | WO |
| WO 0057943 | Oct 2000 | WO |
| WO 0066199 | Nov 2000 | WO |
| WO 0067845 | Nov 2000 | WO |
| WO 0072907 | Dec 2000 | WO |
| WO 0128620 | Apr 2001 | WO |
| WO 0136034 | May 2001 | WO |
| WO 0145773 | Jun 2001 | WO |
| WO 0145912 | Jun 2001 | WO |
| WO 0193920 | Dec 2001 | WO |
| WO 02013682 | Feb 2002 | WO |
| 02062540 | Aug 2002 | WO |
| WO 03004086 | Jan 2003 | WO |
| WO 03008148 | Jan 2003 | WO |
| WO 2004012804 | Feb 2004 | WO |
| WO 2004047899 | Jun 2004 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20050137501 A1 | Jun 2005 | US |